Pharma & Biotech Start-up & Scale-up News

Featured

A clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases.

Pharmaceutical

Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk

28 March 2025

Pharmaceutical

Lexicon pivots back to pipeline after FDA rejection

25 November 2024

Latest Ones To Watch News

Biotechnology

Biohaven wins $600 million investment from Oberland Capital

29 April 2025

Biotechnology

New money for Nova to advance protein therapy for rare skin disorder

29 April 2025

Biotechnology

Medicus to buy Antev for $75 million

28 April 2025

More ones to watch news >

Refine Search

12 3 4 5 6 7 8 9 10 Next page

Pharma & Biotech Start-up & Scale-up News

Featured

Latest Ones To Watch News

Today's issue

Company Spotlight